Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Nucleic Acids Res ; 49(16): 9342-9352, 2021 09 20.
Article in English | MEDLINE | ID: mdl-34403458

ABSTRACT

Polypyrimidine tract-binding protein (PTB) is an RNA binding protein existing both as dimer and monomer and shuttling between nucleus and cytoplasm. However, the regulation of PTB dimerization and the relationship between their functions and subcellular localization are unknown. Here we find that PTB presents as dimer and monomer in nucleus and cytoplasm respectively, and a disulfide bond involving Cysteine 23 is critical for the dimerization of PTB. Additionally, protein disulfide isomerase (PDI) is identified to be the enzyme that catalyzes the de-dimerization of PTB, which is dependent on the CGHC active site of the a' domain of PDI. Furthermore, upon DNA damage induced by topoisomerase inhibitors, PTB is demonstrated to be de-dimerized with cytoplasmic accumulation. Finally, cytoplasmic PTB is found to associate with the ribosome and enhances the translation of p53. Collectively, these findings uncover a previously unrecognized mechanism of PTB dimerization, and shed light on the de-dimerization of PTB functionally linking to cytoplasmic localization and translational regulation.


Subject(s)
Polypyrimidine Tract-Binding Protein/genetics , Protein Disulfide-Isomerases/genetics , Protein Multimerization/genetics , Tumor Suppressor Protein p53/genetics , A549 Cells , Catalysis , Catalytic Domain/genetics , Cell Nucleus/genetics , Cytoplasm/genetics , HEK293 Cells , Humans , Polypyrimidine Tract-Binding Protein/ultrastructure , Protein Binding/genetics , Protein Domains/genetics , RNA-Binding Proteins/genetics , Tumor Suppressor Protein p53/ultrastructure
SELECTION OF CITATIONS
SEARCH DETAIL
...